191 related articles for article (PubMed ID: 26592557)
21. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major.
Kattamis A; Papassotiriou I; Palaiologou D; Apostolakou F; Galani A; Ladis V; Sakellaropoulos N; Papanikolaou G
Haematologica; 2006 Jun; 91(6):809-12. PubMed ID: 16769583
[TBL] [Abstract][Full Text] [Related]
22. New insights into iron regulation and erythropoiesis.
Kim A; Nemeth E
Curr Opin Hematol; 2015 May; 22(3):199-205. PubMed ID: 25710710
[TBL] [Abstract][Full Text] [Related]
23. Hepcidin expression in patients with acute leukaemia.
Cheng PP; Sun ZZ; Jiang F; Tang YT; Jiao XY
Eur J Clin Invest; 2012 May; 42(5):517-25. PubMed ID: 22023453
[TBL] [Abstract][Full Text] [Related]
24. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.
Origa R; Cazzola M; Mereu E; Danjou F; Barella S; Giagu N; Galanello R; Swinkels DW
Haematologica; 2015 May; 100(5):e169-71. PubMed ID: 25596269
[No Abstract] [Full Text] [Related]
25. The relationship between systemic iron homeostasis and erythropoiesis.
Rishi G; Subramaniam VN
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29097483
[TBL] [Abstract][Full Text] [Related]
26. Hepcidin.
Ganz T
Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
28. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
[TBL] [Abstract][Full Text] [Related]
29. The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis.
Brandão M; Oliveira JC; Bravo F; Reis J; Garrido I; Porto G
Haematologica; 2005 Jan; 90(1):31-7. PubMed ID: 15642666
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobinization and functional availability of iron for erythropoiesis in case of thalassemia and iron deficiency anemia.
Bartels PC; Schoorl M; Schoorl M
Clin Lab; 2006; 52(3-4):107-14. PubMed ID: 16584056
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of soluble transferring receptor levels in children with iron deficiency and beta thalassemia trait, and in newborns and their mothers.
Polat A; Kaptanoğlu B; Aydin K; Keskin A
Turk J Pediatr; 2002; 44(4):289-93. PubMed ID: 12458802
[TBL] [Abstract][Full Text] [Related]
32. Correlation between soluble transferrin receptor and serum ferritin levels following bone marrow transplantation for thalassemia.
Centis F; Delfini C; Agostinelli F; Barbanti I; Annibali M; Lucarelli G
Eur J Haematol; 1995 May; 54(5):329-33. PubMed ID: 7781757
[TBL] [Abstract][Full Text] [Related]
33. The effect of erythroid hyperplasia on iron balance.
Pootrakul P; Kitcharoen K; Yansukon P; Wasi P; Fucharoen S; Charoenlarp P; Brittenham G; Pippard MJ; Finch CA
Blood; 1988 Apr; 71(4):1124-9. PubMed ID: 3355891
[TBL] [Abstract][Full Text] [Related]
34. Study of serum hepcidin in hereditary hemolytic anemias.
El Beshlawy A; Alaraby I; Abdel Kader MS; Ahmed DH; Abdelrahman HE
Hemoglobin; 2012; 36(6):555-70. PubMed ID: 23088733
[TBL] [Abstract][Full Text] [Related]
35. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
36. [Serum transferrin receptor in healthy children].
Vázquez López MF; Carracedo Morales A; Muñoz Vico J; Morcillo Llorens R; Calvo Bonachera MD; López Muñoz J; Muñoz Hoyos A
An Esp Pediatr; 2001 Aug; 55(2):113-20. PubMed ID: 11472662
[TBL] [Abstract][Full Text] [Related]
37. Markers of ineffective erythropoiesis in non-transfusion dependent β-thalassaemia.
Khairullah S; Jackson N
Med J Malaysia; 2021 Jan; 76(1):41-45. PubMed ID: 33510107
[TBL] [Abstract][Full Text] [Related]
38. Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators.
Tsuge M; Kodera A; Sumitomo H; Araki T; Yoshida R; Yasui K; Sato H; Washio Y; Washio K; Shigehara K; Yashiro M; Yagi T; Tsukahara H
BMC Pediatr; 2022 Oct; 22(1):622. PubMed ID: 36309641
[TBL] [Abstract][Full Text] [Related]
39. Iron Mining for Erythropoiesis.
Correnti M; Gammella E; Cairo G; Recalcati S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628152
[TBL] [Abstract][Full Text] [Related]
40. Associations between serum transferrin receptor concentrations and erythropoietic activities according to body iron status.
Choi JW; Pai SH
Ann Clin Lab Sci; 2003; 33(3):279-84. PubMed ID: 12956442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
